Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Watanabe

Showing results (461-470 of 510) with videos related to

Pageof 51
Sort By:
Journal of Hepatology|December 7, 2010
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factorsMasayuki Kurosaki, Yasuhito Tanaka, Nao Nishida, et al.
Journal of Gastroenterology and Hepatology|January 15, 2021
Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysisTakeo Yoshihara, Shinichiro Shinzaki, Takahiro Amano, et al.
Journal of Medical Virology|March 2, 2011
Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2bNaoya Sakamoto, Mina Nakagawa, Yasuhito Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 28, 2017
ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirinMiyako Murakawa, Yasuhiro Asahina, Hiroko Nagata, et al.
Journal of Gastroenterology|May 2, 2019
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)Tadakazu Hisamatsu, Shingo Kato, Reiko Kunisaki, et al.
Journal of Gastroenterology and Hepatology|October 1, 2020
Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysisMotoi Uchino, Hiroki Ikeuchi, Keisuke Hata, et al.
Biochemical and Biophysical Research Communications|January 3, 2016
Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cellsSatoshi Otani, Sei Kakinuma, Akihide Kamiya, et al.
Gut|May 8, 2021
Immunoglobulin A-specific deficiency induces spontaneous inflammation specifically in the ileumTakashi Nagaishi, Taro Watabe, Kunihiko Kotake, et al.
Journal of Hepatology|March 23, 2019
Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epitheliumTomoyuki Tsunoda, Sei Kakinuma, Masato Miyoshi, et al.
Journal of Gastroenterology and Hepatology|September 1, 2020
Intestinal cancer in patients with Crohn's disease: A systematic review and meta-analysisMotoi Uchino, Hiroki Ikeuchi, Keisuke Hata, et al.
Pageof 51

Showing results (461-470 of 510) with videos related to

Sort By:
Pageof 51
Journal of Hepatology|December 7, 2010
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factorsMasayuki Kurosaki, Yasuhito Tanaka, Nao Nishida, et al.
Journal of Gastroenterology and Hepatology|January 15, 2021
Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysisTakeo Yoshihara, Shinichiro Shinzaki, Takahiro Amano, et al.
Journal of Medical Virology|March 2, 2011
Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2bNaoya Sakamoto, Mina Nakagawa, Yasuhito Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 28, 2017
ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirinMiyako Murakawa, Yasuhiro Asahina, Hiroko Nagata, et al.
Journal of Gastroenterology|May 2, 2019
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)Tadakazu Hisamatsu, Shingo Kato, Reiko Kunisaki, et al.
Journal of Gastroenterology and Hepatology|October 1, 2020
Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysisMotoi Uchino, Hiroki Ikeuchi, Keisuke Hata, et al.
Biochemical and Biophysical Research Communications|January 3, 2016
Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cellsSatoshi Otani, Sei Kakinuma, Akihide Kamiya, et al.
Gut|May 8, 2021
Immunoglobulin A-specific deficiency induces spontaneous inflammation specifically in the ileumTakashi Nagaishi, Taro Watabe, Kunihiko Kotake, et al.
Journal of Hepatology|March 23, 2019
Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epitheliumTomoyuki Tsunoda, Sei Kakinuma, Masato Miyoshi, et al.
Journal of Gastroenterology and Hepatology|September 1, 2020
Intestinal cancer in patients with Crohn's disease: A systematic review and meta-analysisMotoi Uchino, Hiroki Ikeuchi, Keisuke Hata, et al.
Pageof 51